{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-045305","form_type":"8-K","ticker":"PSTV","cik":"0001095981","company_name":"PLUS THERAPEUTICS, INC.","filed_at":"2025-03-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:02.919162+00:00","generated_at":"2026-05-25T12:42:17.684142+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"confidence":"high","headline":"Plus Therapeutics raises $15M in private placement; exchanges $3.2M in convertible notes","bullets":["Private placement of ~28M shares (or prefunded warrants) at $0.66/unit, each with Series A and B warrants.","Gross proceeds of ~$15M; includes exchange of $3.2M convertible notes for securities in the placement.","Company repurchases $3.4M in notes and 3M warrants for $4.25M, eliminating financing restrictions.","Believes it has regained compliance with Nasdaq minimum stockholders' equity requirement (Rule 5550(b)(1)).","Closing contingent on Nasdaq confirmation by March 31, 2025; funds held in escrow pending."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-045305","json":"https://secwatch.observer/filing/0001193125-25-045305.json","markdown":"https://secwatch.observer/filing/0001193125-25-045305.md","text":"https://secwatch.observer/filing/0001193125-25-045305.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1095981/000119312525045305/0001193125-25-045305-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1095981/000119312525045305/d875007d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T12:42:17.684142+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}